IOL CHEMICALS & PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE552.50-1.6 (-0.29 %)
PREV CLOSE ( ) 554.10
OPEN PRICE ( ) 565.00
BID PRICE (QTY) 552.50 (115)
OFFER PRICE (QTY) 553.00 (20)
VOLUME 18409
TODAY'S LOW / HIGH ( )548.45 569.00
52 WK LOW / HIGH ( )147.35 898.4
NSE552.95-1.2 (-0.22 %)
PREV CLOSE( ) 554.15
OPEN PRICE ( ) 563.70
BID PRICE (QTY) 552.60 (118)
OFFER PRICE (QTY) 552.70 (5)
VOLUME 240392
TODAY'S LOW / HIGH( ) 548.15 567.35
52 WK LOW / HIGH ( )146.3 898.9
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1986
Management Info
Rajender Mohan Malla - Chairman Varinder Gupta - Managing Director
Registered Office

Address Village & Post Office,Handiaya,Fatehgarh Chhanna Road,
Barnala,
Punjab-148107

Phone +91-1679- 244701 / 244702 / 244703 / 04 / 05 / 06 / 07

Email contact@iolcp.com

Website www.iolcp.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX
NEWS
20Feb IOL Chemicals & Pharmaceuticals inform
Pursuant to Regulation 47 and other applicable provisions of the SEBI (L..
02Feb Board Meeting Intimation for Notice O
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of..
23Jan IOL Chemicals & Pharmaceuticals inform
Pursuant to Regulation 47 and other applicable provisions of the SEBI (L..
04Aug IOL Chemicals spurts on reporting 49%
IOL Chemicals & Pharmaceuticals is currently trading at Rs. 756.50,..
03Aug IOL Chemicals and Pharmaceuticals repo
IOL Chemicals and Pharmaceuticals has reported results for first quarter..
Financials
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit1148.13612.9
Gross Profit 1536.3 5332.4
Operating Profit 1650.65899
Net Sales 5130.118944.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 14489.00 (0.64%)
M.Cap (Rs. in Cr)30642.66
Divis Lab (BSE)
 3433.90 (1.95%)
M.Cap (Rs. in Cr)90330.99
Pfizer (BSE)
 4614.25 (1.40%)
M.Cap (Rs. in Cr)21121.73
Alkem Laboratories (BSE)
 2781.35 (2.31%)
M.Cap (Rs. in Cr)32910.27
Sanofi India (BSE)
 8324.25 (0.67%)
M.Cap (Rs. in Cr)19269.61
Shareholding Pattern
NON-INSTITUTION 48.48%
PROMOTERS 43.69%
MUTUAL FUNDS/UTI 0.03%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Jerina George, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.